Christopher Bowden
Director/Board Member bei Cedilla Therapeutics, Inc.
Profil
Christopher J.
Bowden currently works at Cedilla Therapeutics, Inc., as Director from 2021.
Dr. Bowden also formerly worked at Bristol Myers Squibb Co., as Executive Director-Europe, Middle East & Africa from 2003 to 2006, Alaunos Therapeutics, Inc., as Independent Director from 2019 to 2023, Viridian Therapeutics, Inc., as Independent Director from 2017 to 2020, Genentech, Inc., as VP-Product Development Oncology from 2006 to 2014, Agios Pharmaceuticals, Inc., as Chief Medical Officer from 2014 to 2021, and Roche Group, as Member from 2006 to 2014.
Dr. Bowden received his undergraduate degree from Lake Forest College and doctorate degree in 1988 from Drexel University College of Medicine.
Aktive Positionen von Christopher Bowden
| Unternehmen | Position | Beginn |
|---|---|---|
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 21.04.2021 |
Ehemalige bekannte Positionen von Christopher Bowden
| Unternehmen | Position | Ende |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 30.03.2023 |
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.09.2021 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 01.10.2020 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.05.2014 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Christopher Bowden
| Lake Forest College | Undergraduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
